Five Reasons Your Margins May Be Wrong, and How to Fix Them - Register for Our Free Webinar
Five Reasons Your Margins May Be Wrong, and How to Fix Them - Register for Our Free Webinar
Top Stories | Cannabis Business Times
Subscribe
Sign In
Continue to Site
»
Site will load in
15
seconds
Continue to Site »
X
Top Stories
DEA’s Final Schedule III Case Leads
CBT’s
Top Stories in August
The Drug Enforcement Administration tried to discredit nearly all opposing witnesses who testified during the rescheduling hearing in its post-hearing brief.
The Flavor Labs Don’t Measure: What is Terpene Testing Missing?
Standard terpene testing is optimized for volatile compounds but misses the compounds that seem to drive lingering flavor in cannabis flower.
DEA Judge Releases Transcripts for Cannabis Rescheduling Hearing
With the fully corrected transcripts now part of the public record, the judge who oversaw the hearing’s proceedings now must make a recommendation.
New Mexico Cannabis Businesses Ask Judge to Halt New Track-and-Trace System
State licensees are seeking injunctive relief over New Mexico’s planned rollout of a replacement seed-to-sale system they say is not proven.
Michigan GOP Gubernatorial Nominee Plans to Repeal 24% Cannabis Tax, End Unregulated Hemp Sales
John James, who is vacating his seat as a U.S. congressman to run on the state’s Republican ticket for governor, outlined his cannabis reform policies.
DEA Judge Orders 294 Corrections to 2,500-Page Cannabis Hearing Transcript
The DEA’s administrative law judge said the fully corrected transcript for the cannabis rescheduling hearing will be made public no later than Aug. 26.
55% of Massachusetts Voters Oppose Repealing Cannabis Laws
A majority of registered voters plan to reject a November ballot question that would backtrack the state’s adult-use legalization laws, according to a new poll.
The Massive Financial Penalty of Ignoring Microbial Risk in Cannabis Production
Part III of ‘The Cost of Doing Nothing’ series examines how airborne pathogen pressure and compliance testing turn microbial outbreaks into immediate, measurable losses, ranging from hundreds of thousands to millions of dollars annually – losses set to grow as Schedule III and export markets raise the testing bar.
US House Members Push Trump Administration for Guidance on Schedule III Federal Framework
A bipartisan quartet of lawmakers sent a letter to Trump and three cabinet members, asking for clarity on the federal policy for medical cannabis.
DEA Makes Final Schedule III Case, Tries to Discredit Nearly All Opposing Witnesses
The government’s final brief for the cannabis rescheduling hearing focuses on currently accepted medical use, a scientific and medical analysis, and the opposition’s ‘so-called experts.’
Georgia Cannabis Regulators Propose Allowing USPS Deliveries Under Rescheduling
The state’s 45,000-plus medical cannabis patients could receive dispensary products through federal or private mail carriers under the proposed rule change.
Virginia’s 2mg THC Cap on Intoxicating Hemp Products Goes Into Effect
A federal judge denied a request for a temporary restraining order against a provision in the state budget that eliminates a 25-to-1 CBD-to-THC rule.
Page 1 of 283
Next Page
